Sentences with phrase «regenerative medicine lab»

Not exact matches

Researchers at Wake Forest Institute for Regenerative Medicine have reached important milestones in their quest to engineer replacement tissue in the lab to treat digestive system conditions — from infants born with too - short bowels to adults with inflammatory bowel disease, colon cancer, or fecal incontinence.
Developmental geneticist Edwina McGlinn's return to Australia to start her own lab next January at the Australia Regenerative Medicine Institute (ARMI) at Monash University in Melbourne will also be a milestone for Australian science: 35 - year - old McGlinn will be the first group leader appointed under a joint initiative between Australia and the European Molecular Biology Laboratory (EMBL).
«Our paper is a blueprint of how the cartilage - producing cell, called a chondrocyte, is made and maintained by Sox9,» said He, a postdoctoral research associate in the lab of Andy McMahon, director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC.
In a boon to stem cell research and regenerative medicine, scientists at Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a «roadmap» for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable properties as cells in our own bodies.
Anthony Atala, a surgeon and director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine in Winston - Salem, North Carolina, reported that artificial bladders can be grown in the lab from a patient's own cells and successfully implanted.
Last week on Friday, Lab Land attended the annual Regenerative Engineering & Medicine center get - together to hear about progress in this exciting area.
The Okyanos Center for Regenerative Medicine was founded in 2011 to offer patients the most advanced and safe medical treatments in regenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cRegenerative Medicine was founded in 2011 to offer patients the most advanced and safe medical treatments in regenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cell Medicine was founded in 2011 to offer patients the most advanced and safe medical treatments in regenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cregenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cell medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cell therapy.
The two co-founded the lab's first spinoff laboratory in its 115 - year history in 2013, regenerative medicine company Novo Biosciences Inc..
In addition, the lab coordinates with other local and international training programs within the areas of psychiatry, neurology, neuroregeneration, stem cell biology, and regenerative medicine.
Dr. Masayo Yumoto, team leader of Regenerative Medicine Research & Planning Division, Rohto Pharmaceutical Co., Ltd., has been holding a leadership role in the joint research lab at the Institute of Medical Sciences, University of Tokyo, to develop next generation cell culture method using human mesenchymal stem cells.
Since 2003, Regenerative Medicine Foundation has built the strongest, most comprehensive and trusted global network for Regenerative Medicine, uniting the world's leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies and patient organizations.
Yamanaka and his lab are working on ways to better understand exactly what happens when iPS cells are created and to make the process more efficient and viable for regenerative and personalized medicine.
GHOSH: The interactions between basic science labs, industry and patient foundations are changing and proving very productive, and from the beginning, the California Institute for Regenerative Medicine has had a huge influence.
Other contributors to the study include Yasuhiko Kawakami, PhD., Masanobu Morita, PhD., and Concepción Rodríguez - Esteban, PhD., all currently in the Belmonte lab; and former Belmonte lab members, Ángel Raya, PhD., now at the Center for Regenerative Medicine of Barcelona, and Takaaki Matsui, PhD., now at the Nara Institute of Science and Technology in Japan.
Attendees will earn 11 continuing education credits, with the option of adding a regenerative medicine wet - lab to advance their expertise (for an additional four CE credits).
a b c d e f g h i j k l m n o p q r s t u v w x y z